Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
World Neurosurg ; 142: 13-16, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32562904

RESUMO

BACKGROUND: Clinical evidence to support the use of mechanical thrombectomy (MT) for posterior cerebral artery P2 segment occlusion (P2O) has not been established, and hemiplegia due to P2O improved by MT to our knowledge has not yet been reported. We report 2 cases of P2O with hemiplegia improved by MT. CASE DESCRIPTION: In case 1, a 68-year-old man was admitted with right hemiplegia and dysesthesia (National Institutes of Health Stroke Scale score 14). Head magnetic resonance imaging showed acute ischemia in the left inferolateral thalamus and posterior limb of the internal capsule. Angiography showed left P2O, which was recanalized after MT. Hemiplegia improved immediately following recanalization, and modified Rankin Scale score at discharge was 0. In case 2, a 69-year-old man was admitted with left hemiplegia and dysesthesia (National Institutes of Health Stroke Scale score 8). Head magnetic resonance imaging showed acute ischemia in the right inferolateral thalamus and posterior limb of the internal capsule. Angiography showed right P2O, which was recanalized after MT, as in case 1. His symptoms resolved completely. CONCLUSIONS: P2O may cause severe motor deficit. In such cases, MT may contribute to safely improving patients' deficits.


Assuntos
Transtornos Cerebrovasculares/cirurgia , Debilidade Muscular/cirurgia , Artéria Cerebral Posterior/cirurgia , Trombectomia/métodos , Idoso , Transtornos Cerebrovasculares/complicações , Transtornos Cerebrovasculares/diagnóstico por imagem , Humanos , Masculino , Debilidade Muscular/diagnóstico por imagem , Debilidade Muscular/etiologia , Artéria Cerebral Posterior/diagnóstico por imagem
2.
Cancer Sci ; 98(8): 1147-51, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17532755

RESUMO

Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of asbestos-related mesothelioma is estimated to be approximately 30-40 years. Once mesothelioma has occurred, there is no effective treatment. So, identification of tumor markers and a method for early diagnosis using such markers are urgently needed. Recently, several enzyme-linked immunosorbent assay systems for Erc/mesothelin have been developed, the reported usefulness of which has been assessed and demonstrated as a diagnostic tool. Asbestos-related mesothelioma should be ascribed as a typical environmental carcinogen. In this review, we will present asbestos-related mesothelioma for the study of problems in environmental carcinogenesis.


Assuntos
Amianto/toxicidade , Biomarcadores Tumorais/análise , Neoplasias Pulmonares/etiologia , Glicoproteínas de Membrana/análise , Mesotelioma/induzido quimicamente , Mesotelioma/etiologia , Proteínas Oncogênicas/análise , Neoplasias Peritoneais/etiologia , Neoplasias Pleurais/etiologia , Animais , Exposição Ambiental , Ensaio de Imunoadsorção Enzimática , Proteínas Ligadas por GPI , Mesotelina , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA